期刊文献+

青蒿琥酯-壳聚糖纳米粒的制备及质量评价 被引量:6

Preparation and quality assessment of artesunate-chitosan nanoparticles
原文传递
导出
摘要 目的:研制青蒿琥酯-壳聚糖纳米粒(ART-CS-NPs)并进行质量评价。方法:采用离子交联法制备ART-CS-NPs,以包封率和粒径为考察指标,通过单因素、正交设计试验优化制备工艺及处方,通过形貌观察、粒径和电位测定、体外释药考察对其进行质量评价。结果:以优化处方、工艺制备的ART-CS-NPs在透射电镜下呈现圆整、均匀的球形微粒,形态规则完整。粒径为(186.8±12.2)nm,PDI为(0.259±0.004),Zeta电位为(+31.7±1.5)mV,包封率为(69.4±1.4)%,载药量为(19.67±0.32)%。ART-CS-NPs体外释放曲线以Higuchi方程拟合结果最好。结论:离子交联法所制ART-CS-NPs形态规则完整,载药量、包封率较高,体外释放具有缓释作用,稳定性较好。 OBJECTIVE To study the formulation and preparation of artesunate-ehitosan nanoparticles (ART-CS-NPs). METHODS The ART-CS-NPs were prepared by ionic cross-linking. A single factor experiment and orthogonal experiment were used to inspect the effect regularity of various factors on the encapsulation efficiency and particle size. The ART-CS-NPs were evaluated by morphological observation, the particle size and Zeta potential measurement, in vitro release inspection. RE- SULTS AR'r C~%NPs prepared by optimized formulation were approximate to spheres, smooth with almost homogeneous structure. The mean diameter of ART-CS-NPs was (186. 8 + 12. 2) nm, PDI was (0. 259 -+ 0. 004) and Zeta potential was ( + 31.7 + 1.5)mV. The entrapment efficiency and drug-loading efficiency were (69. 4 + l. 4) ~/00 and (19. 67 + 0. 32) % respec- tively. The in vitro profiles of ART CS-NPs could be described by Higuchi equation. CONCLUSION ART-CS-NPs prepared by ionic cross-linking showed smooth surfaces with almost homogeneous structure. The entrapment efficiency and drug-loading ef- ficiency could meet the requirement of pharmaceutical design. Drug release property in vitro and physical stability of ART-CS- NPs was good.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2013年第5期349-355,共7页 Chinese Journal of Hospital Pharmacy
基金 湖北省卫生厅血防项目(编号:XF2010-20)
关键词 青蒿琥酯 壳聚糖 纳米粒 离子交联法 体外释放 artesunate chitosan nanoparticles ionic cross-linking in vitro release
  • 相关文献

参考文献8

  • 1王博,张向阳,郑友兰.青蒿琥酯的药理作用研究新进展[J].吉林农业(学术版),2010(6):46-47. 被引量:8
  • 2Konkhnalla VB, McCubrey JA, Efferth T. The role of down stream signaling pathways of the epidermal growth factor re ceptor for artesunate's activity in cancer cells[J]. Current Cane er Drug Targets, 20(19,9 ( 1 ) : 72-800.
  • 3Efferth T,Romero MR,Wolf DG,et al. The antiviral activities of artemisinin and artesunate[J]. Clin Infect Dis, 2008,47 (6): 804-811.
  • 4Liu H,Gao CY. Preparation and properties of ionically cross linked chitosan nanoparticles [J]. Polym Adv Technol, 2009, 20(7):613-619.
  • 5Thanoo BC,Sunny MC,Jayakrishnan A. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceutieals[J]. J Pharm Pharmacol,1992,44(4):283-286.
  • 6Berger J, Reist M, Mayer JM, et al. Structure and interactions in covalently and ionically cross linked chitosan hydrogels for biomedical applications [J]. Eur J Pharm Biopharm, 2004, 57 (1):19-34.
  • 7He P, Davis SS, Illum L. Chitosan microspheres prepared by spray drying [J]. Int J Pharm, 1999,187 (1): 53-65.
  • 8Calvo P, Remu n-L pez C, Vila-Jato JL,et al. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers [J]. J Appl Polymer Sci, 1997,63(1): 125-132.

二级参考文献24

共引文献7

同被引文献58

  • 1冀艳艳,韩国华,朱澄云.改善口服难溶性药物生物利用度的方法[J].中国药剂学杂志(网络版),2012(5):86-92. 被引量:14
  • 2张兰凤,孟凡迅,张金业,段文娟,李海燕,徐芬芬,仇芳芳.长春瑞宾渗漏后皮下注射解毒剂的实验研究[J].中国实用护理杂志,2005,21(7):3-5. 被引量:17
  • 3袁琼英,刘厚钰,周康,石碧坚.甘草甜素脂质体和甘草甜素的药动学比较[J].中国新药杂志,2005,14(7):903-905. 被引量:17
  • 4陈娇婷,王跃生,杨范莉,詹怡飞.HPLC法测定心可舒胶囊中丹酚酸B[J].中草药,2006,37(8):1181-1182. 被引量:13
  • 5王忠诚.神经外科学[M].武汉:湖北科学技术出版社,2005.620-621.
  • 6Itoh T, Tabuchi M, Mizuguchi N, et al. Neuroprotective effect of(-)-epigallocatechin-3-gallate in rats when administered pre-or post-traumatic brain injury[J]. J Neural Transm, 2013, 120(5):767-783.
  • 7Pardridge W M. Brain Drug Targeting[M]. Cambridge:Cambridge University Press, 1998.
  • 8Baltzley S, Mohammad A, Malkawi A H, et al. Intranasal drug delivery of olanzapine-loaded chitosan nanoparticles[J]. AAPS Pharm Sci Tech, 2014, 15(6):1598-1602.
  • 9Jafarieh O, Md S, Ali M, et al. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting[J]. Drug Dev Ind Pharm, 2015, 41(10):1674-1681.
  • 10Fazil M, Md S, Haque S, et al. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting[J]. Eur J Pharm Sci, 2012, 47(1):6-15.

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部